
Daniel R Getts
Articles
-
22 hours ago |
genengnews.com | John Sterling |Daniel R Getts
Credit: Myeloid Therapeutics Imagine dedicating your life to science, only to see your work undermined by conspiracy theories and political noise. Case in point: the Trump administration recently canceled over $766 million in federal funding allocated to Moderna to develop an mRNA-based H5N1 bird flu vaccine. Despite promising early results, the program was abruptly halted. Health Secretary Robert F. Kennedy Jr., a vocal critic of mRNA, cited concerns about safety and transparency.
-
Jan 9, 2025 |
timmermanreport.com | Daniel R Getts
Most US biotech entrepreneurs and investors don’t consider Australia a thriving global hub. But there are compelling reasons to take another look at what’s happening there now. Australia has become more attractive based on its willingness to allow fast, affordable clinical trials to help early-stage developers gather human data on new drug candidates. That low-cost,... Read More
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →